2024 has been a year of exciting advancements at Aspen Biosciences, marked by the expansion of our Pipeline and PharmExchange platforms and the launch of innovative features designed to empower drug discovery efforts and to improve their capital efficiency. We’re thrilled to share some of the highlights:
New Modules:
- PharmExchange Expansion: In 2023, we released our PharmExchange service to enable biotech companies to request services from CROs, and to track the progress of those requests. This year, we’ve broadened the scope of PharmExchange to encompass modules beyond chemistry, including Protein Production, and Assay Request Management, fostering improved collaboration and reducing the time and effort required to manage requests across the research organisation.
- Chemistry Module: At this year’s SLAS meeting, we released our Chemistry module. This new module streamlines the compound synthesis process by integrating with Pipeline’s Inventory module, thus enabling scientists to determine the availability of building blocks. The Chemistry module’s workflow system makes it possible to direct synthesis requests to either internal chemistry groups or to CROs via PharmExchange request queues. Compounds can be shuttled from synthesis requests, to purification request queues, and assay queues in a single workflow. Requests can be split into multiple workflows to allow scientists to parallelise their work.
- Planning Module: At this year’s Why Summits Project & Portfolio Management conference, we launched Pipeline’s new Planning module. This new module builds on the Project Management module, and allows scientists to create Milestones, Target Product Profiles, Assay Plans, Task Plans and more. This template-driven module makes it easy for scientists and research PMs to plan projects, and turn those plans into a manageable set of actions. The Planning module helps team members answer questions like:
- What assays need to be run in order to answer these key questions for our current milestone?
- What will it cost to run the assays?
- How much of each compound do we need to synthesise in order to run the assays in our Assay Plan?
- How many people will it take to run these assays?
- What risks and issues do we face during this milestone?
- What decisions did we take?
- What lessons did we learn along the way and how can we apply them to improve the efficiency of our operations?
New Features:
- Calculation Engine Integration: This powerful tool makes it possible to incorporate AI/ML algorithms and custom calculations into your workflows and request queues. With support for multiple scripting languages including Python, Groovy, Javascript and more, the Calculation Engine makes it possible to customise the business logic of the Pipeline system. The Calculation Engine is currently implemented in the Chemistry module, and will be rolled out in Literature Management, Target Management, Project Management, Planning, Assay Request Management, Protein Production, Registration, and Inventory in the coming months.
Overall, these new modules within the Pipeline platform contribute to improved capital efficiency by reducing costs, accelerating research timelines, and fostering better communication and collaboration between biotech companies and CROs. By streamlining processes, optimising resource allocation, and enhancing decision-making, these modules enable drug discovery companies to maximize their research investments and increase the likelihood of success.
These achievements underscore our commitment to delivering cutting-edge solutions that address the evolving needs of the drug discovery landscape. We’re excited to continue pushing the boundaries of innovation in 2025 and beyond, empowering researchers to accelerate the development of new life-saving therapies.
To learn more about the Pipeline and PharmExchange platforms and how they can help improve the efficiency of your drug discovery organisation, contact us at info@aspen.bio.